Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06657404
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-23
Brief Title:
The Modified Pills-in-the-Pocket Strategy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Modified Pills-in-the-Pocket Strategy -The Combined Effect of Amiodarone Bisoprolol and Digoxin in the Treatment of Recurrent Atrial Arrhythmia for Non-Paroxysmal Atrial Fibrillation After Catheter Ablation A Multicenter Prospective Randomized Open-Label Blinded Endpoint Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ABD-AF
Brief Summary:
This is a multicentre prospective randomised controlled study of 328 patients with non-paroxysmal AF within 5 years of first diagnosis of AF with recurrent atrial arrhythmias after first catheter ablation randomly divided in a 11 ratio into a study group treated with triple AADs amiodarone bisoprolol digoxin and a control group treated with conventional AADs amiodarone bisoprolol digoxin The study group was treated with triple AADs amiodarone bisoprolol and the control group was treated with conventional AADs amiodarone bisoprolol with the aim of comparing the efficacy and safety of the two groups in terms of reversion of SR which may provide an effective option of pocket drug reversion for patients with recurrence of SR after AF catheter ablation
Translated with DeepLcom free version
Translated with DeepLcom free version
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None